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with the efﬁcacy of other known Akt inhibitors. Our ﬁndings suggest that SK&F 96365 can be a useful agent for
delineating the molecular mechanisms underlying crosstalk among cell death pathways.ntial channel; VSMC, vascular
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Vascular smooth muscle cells (VSMCs) play a crucial role in the
regulation of blood vessel wall integrity and vascular tone. In
pathological conditions, such as atherosclerosis and restenosis,
VSMCs undergo phenotypic switching from a quiescent contractile
to a proliferative synthetic phenotype [1,2]. Recent studies have
shown that aberrant regulation of transient receptor potential (TRP)
calcium channels underlies the pathogenesis of vascular proliferative
diseases [3–5], suggesting that TRP channels can be promising targets
for treatment of vascular proliferative diseases.
SK&F 96365, an imidazole derivative, has been widely used as a
pharmacologic inhibitor of TRP channels (typically in the range of
10–100 μM) to assess the role of TRP channels in various pathophys-
iological processes [6,7]. However, growing evidence suggests that
SK&F 96365 affects several cellular processes, including cell cyclearrest or cell death, in certain cells via uncharacterized off-target
mechanisms [8–10]. Thus, the pharmacologic effects of SK&F 96365
need to be carefully evaluated to avoid misinterpretation of the data.
Nonetheless, little has been known about the mechanisms underlying
off-target effects of SK&F 96365.
Apoptosis and autophagy are self-destructive processes that play a
crucial role in the pathophysiological remodeling of injured tissues
[11,12]. Deregulation of these processes is associated with various
human diseases, including vascular proliferative diseases and cancers
[13]. Apoptosis and autophagy share many common molecular
regulators or pathways [12,14]. For example, Akt, mTOR or Bcl-2
inhibits both apoptosis and autophagy [14], whereas BNIP3 induces
both processes [12]. However, the relationship between apoptosis and
autophagy is very complex: they are synergistic or antagonistic to
each other to induce cell death in a cell type- and/or context-speciﬁc
manner [12]. Moreover, under certain conditions, the concurrent
inhibition of apoptosis and autophagy can lead to necrotic cell death
[15,16]. Therefore, the better understanding of crosstalk among cell
death pathways may be a key to develop therapeutic strategies to
improve the efﬁcacy of the drugs targeting proliferative diseases,
including restenosis and cancers.
As an attempt to understand the off-target action of SK&F 96365, we
have investigated the mechanisms underlying cell death induced by
SK&F 96365. In this study, we showed that SK&F 96365 induces both
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(s). We found that SK&F 96365 has the ability to inhibit Akt–mTOR
signaling pathways with similar IC50 values of other known Akt
inhibitors. Our ﬁndings suggest that SK&F 96365 is applicable as a
novel Akt-targeting agent for the treatment of proliferative diseases.2. Materials and methods
2.1. Cell culture and reagents
A7r5 cells were purchased from ATCC. The cells were cultured in
DMEM supplemented with 10% fetal bovine serum, penicillin (100 U/
ml), and streptomycin (100 μg/ml). All cell culture agents used were
obtained from Hyclone or Invitrogen. SK&F 96365, LOE 908, Pyr2, and
Pyr3 were purchased from Tocris. All other reagents not speciﬁed were
supplied by Sigma.2.2. Cell viability assay
A7r5 cells were grown in 12-well culture plates. MTT or LDH release
assay was used to assess cell viability according to the manufacturers'
instructions (Sigma or Promega). The assays were quantitated by
measuring the absorbance at 570 or 490 nm onmicroplate spectropho-
tometer (ASYS).100
120
*
0 μM
A C
40
60
80
**
***
Ce
ll v
ia
bi
lity
 (%
)
0 1.56 3.125 6.25 12.5 25
0
20
***
***
SK&F 96365 (μM)
B 6.25 μM
200
250
300 0
3.125
6.25
12.5
100
150
Ce
ll v
ia
bi
lity
 (%
)
0
50
0 1 2 3
Time (day)
Fig. 1. SK&F 96365 induces cell death in A7r5 cells. (A) The cells were incubated with SK&F
used as vehicle. Cell viability is expressed as a relative value to that of the untreated cells wh
(B) Time course response to SK&F 96365. Cell viability is expressed as a relative value to
(C) Time-lapse image of A7r5 cells treated with SK&F 96365. Of the images obtained every2.3. Flow cytometry analysis
A7r5 cells were ﬁxed with 70% ethanol and then labeled with
propidium iodide solution (50 μg/ml) containing RNase A (100 μg/ml).
Thepercentage of sub-G1 cellswas obtainedby cell cycle proﬁle analysis
using ﬂow cytometry (BD Biosciences). ModFitLT V3.0 software was
used for data analysis.
2.4. Caspase assay
The activity of caspase-3 and -9 from A7r5 cells was determined in
microtiter plates as previously described [17]. Ac-DEVD-P-nitroaniline
and Ac-LEHD-P-nitroaniline (AG scientiﬁc) at 2 mM were used for
caspase-3 and -9 assays, respectively. P-nitroaniline was used to
generate the standard curve to evaluate the concentration of the
products. A pan-caspase inhibitor zVAD-fmk (Calbiochem) was used to
validate the assaymethod. The absorbancewasmeasured at 405 nmon
microplate spectrophotometer (ASYS).
2.5. Assessment of mitochondrial membrane depolarization
Mitochondrial membrane depolarization was evaluated using JC-1
ﬂuorescence probe according to the manufacturer's instructions
(Molecular Probes). A7r5 cells were labeled with 2 μM JC-1 for 30 min
at 37 °C and then analyzed by ﬂow cytometry using 488 nm excitation
with 530/30 or 585/42 nmbypass emission ﬁlters. The cellswithout red96365 at the indicated concentrations for 72 h prior to MTT assays. Distilled water was
ich is set to 100%. The ﬁgures showmean±SEM (n=4). *Pb0.05, **Pb0.01, ***Pb0.005.
that of the cells treated with vehicle and harvested at zero time which is set to 100%.
1 min for 24 h, the selected images were shown.
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membrane depolarization.
2.6. Intracellular Ca2+ measurement
The detached A7r5 cells were incubated with 5 μM Fura-2-AM and
0.02% Pluronic F-127 (Molecular probes) in normal Tyrode's solution
(10 mMHEPES, 145 mMNaCl, 3.6 mMKCl, 1 mMMgCl2, 1.3 mMCaCl2,
and 5 mM glucose) for 50 min at 37 °C. After washing twice, the cells
were resuspended with normal Tyrode's solution. Fluorescence
emission at 510 nm was measured with excitation at 340/380 nm in
a stirred quartz-microcuvette of ﬂuorescence spectrophotometer
(Photon Technology Instrument). Maximum and minimum ﬂuores-
cence values at 380 nm (Fmax and Fmin) were calibrated by addition of
0.2% Triton X-100 and 10 mM EGTA, respectively. The [Ca2+]cyt was
calculated from the equation, [Ca2+]=Kd×β×(R−Rmin)/(Rmax−R)
where Kd is the dissociation constant for Fura-2 (224 nM), β is Fmin/
Fmax, and R is F340/F380.
2.7. Quantitative analysis of GFP-LC3 dot
A7r5 cells were transfected with GFP-LC3 using Fugene-6 (Roche).
The cells expressing GFP-LC3 were directly observed by FluoView 1000
confocal microscopy (Olympus). The number of GFP-LC3 dots in each
cell (total 40–50 cells) was counted in at least ﬁve independent visual
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Fig. 2. SK&F 96365 triggers apoptosis in A7r5 cells. The cells were cultured with SK&F 96365
JC-1 dye (B). (A) Cell fraction is expressed as the percentage of sub-G1 cells. (B) Mitochond
which is set to 100%. (C) The cells were cultured with SK&F 96365 at the indicated concentra
as 100%. Pan-caspase inhibitor zVAD-fmk (zVAD) at 20 μM was used to validate the analy
indicator in A7r5 cells treated with SK&F 96365 at 6.25 μM. CFP (excitation 440 nm/emission
1 min with a time-laps epiﬂuorescecnt microscope. The ratio images of FRET/CFP were pr
(E) FRET/CFP emission ratio changes of the SK&F 96365-treated cells. The emission ratio valu
(n=4–6). *Pb0.05, **Pb0.01, ***Pb0.005.2.8. Western blot analysis
The crude extracts from A7r5 cells were prepared by incubation
with RIPA buffer containing protease and phosphatase inhibitor
cocktails (Calbiochem). The proteins were resolved in 6, 10, or 15%
SDS–PAGE and analyzed with the antibodies indicated. Antibodies
to cleaved caspase-3, Akt, pAktS473, pGSK3βS9, mTOR, pmTORS2448,
Mcl-1, Beclin-1, and BINP3 were purchased from Cell Signaling.
Antibody to LC-3 was obtained from Medical and Biological
Laboratories. Antibodies to Bcl-2, GSK3β, Bax, and GAPDH were
supplied by Santa Cruz. Antibody to PARP was obtained from BD
Pharmingen.2.9. Live cell imaging
A7r5 cells were plated onto a collagen-coated 35-mm glass-base
dish (Asahi techno glass) and grown overnight at 37 °C. To obtain phase
contrast images, the cells were placed in an incubation chamber
equipped with a time-lapse imaging system (Nikon BioStation IM). The
images were captured at 5 min intervals. To perform time-lapse image
analysis for autophagy, the cells transfected with GFP-LC3 were imaged
with a Leica DM IRB inverted microscope (Leica Microsystems)
equipped with Cascade 512B (EMCCD) camera (Roper Scientiﬁc). All
images were processed using MetaMorph software (Universal
Imaging).C
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at the indicated concentrations for 24 h prior to labeling with propidium iodide (A) or
ria membrane depolarization is expressed as a relative value to that of untreated cells
tions for 24 h prior to caspase assays. Caspase activity from untreated cells is expressed
tical method employed. (D) Caspase-3 activity was monitored by SCAT3 FRET-based
480 nm) and FRET (excitation 440 nm/emission 530 nm) images were obtained every
epared by using MetaMorph software and the representative images were presented.
es were normalized to those of the record-starting time. The ﬁgures show mean±SEM
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A7r5 cells were cultured on a collagen-coated 35-mm glass-base
dish and transfected with caspase-3 FRET-based indicator (SCAT3) as
previously described [18]. FRET images were captured by a Leica DM
IRB inverted microscope equipped with Cascade 512B (EMCCD)
camera, excitation and emission ﬁlter wheels (MAC5000, Ludl
Electronic Products). All systems were controlled by MetaMorph
software. The ﬂuorescent images were sequentially obtained through
CFP and FRET ﬁlter channels. Filter sets and ND ﬁlters were purchased
from Chroma Technology (Rockingham). The images were obtained
by using the 2×2 or 3×3 binning mode and 100-ms exposure time.
The ratio image of FRET/CFP was created with MetaMorph software.
2.11. Statistic analysis
All data are expressed asmean±SEM. Comparison of means among
experimental groups was carried out with ANOVA followed by a post
hoc test. Pb0.05 was considered statistically signiﬁcant.
3. Results
3.1. SK&F 96365 induces cell death in A7r5 cells
To ascertain whether SK&F 96365 kills A7r5 cells, we performed
MTT assays. Viable cell population was gradually reduced in relation0 
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Fig. 3. SK&F 96365 induces autophagy in A7r5 cells. (A) A7r5 cells expressing GFP-LC3 were d
(B) The number of GFP-LC3 dots in each cell was counted in at least ﬁve independent visua
assessed by western blot analysis using the crude extract prepared from the cells treated w
protease inhibitors, were included to corroborate LC3-II production. Western blots are repres
in live cells following treatment with SK&F 96365. Live-cell imaging was performed on A7
acquired every 1 min with a time-laps epiﬂuorescecnt microscope and the representative ito concentrations of SK&F 96365 with the IC50 value of 3.18 μM
(Fig. 1A), which was veriﬁed by quantitating cell growth over time
(Fig. 1B). To conﬁrm MTT assay results further, we monitored SK&F
96365-induced cell death by a time-lapse imaging system. The cells
were detached upon SK&F 96365 over times compared to vehicle
(Fig. 1C). Thus, our results demonstrate that SK&F 96365 induces cell
death in A7r5 cells.3.2. SK&F 96365 triggers apoptosis in A7r5 cells
To determine whether SK&F 96365 induces cell death by
apoptosis, we ﬁrst analyzed cell cycle proﬁles. Flow cytometric
analysis showed that the percentage of sub-G1 phase cells markedly
increases in the cells treated with SK&F 96365 in a dose-dependent
manner (Fig. 2A). In addition, SK&F 96365 elevated mitochondrial
membrane depolarization, an early event of an intrinsic apoptosis
signaling (Fig. 2B). Thus, our ﬁndings suggest that SK&F 96365
induces apoptosis via intrinsic apoptotic mechanism(s).
To corroborate our observations, we performed caspase activity
assays. SK&F 96365 increased the activity of caspase-3 and -9, which
was restrained by zVAD-fmk, a pan-caspase inhibitor (Fig. 2C). These
results were further conﬁrmed by time-lapse image analysis using
caspase-3 FRET-based indicator (SCAT3). A decrease in FRET signalswas
observed after 5 h of treatment with SK&F 96365, which means that
SK&F 96365 activates caspase-3 (Fig. 2D and E). In addition, Western
blot analysis showed that SK&F 96365 produces cleaved caspase-3, anh 0.5 h 1 h
5 h 2 h 2.5 h
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the expression of pro-survival Bcl-2 andMcl-1, whereas it elevated that
of anti-survival Bax, Beclin-1, and BNIP3 (SFig. 1). These results
demonstrate that SK&F 96365 triggers apoptosis. Nonetheless, zVAD-
fmk failed to rescue cell death (SFig. 2), suggesting that apoptosis is not
the sole mechanism for SK&F 96365-induced cell death.
3.3. SK&F 96365 induces autophagy in A7r5 cells
We then questioned whether SK&F 96365 induces cell death via
autophagy. Fluorescence image analysis showed that distinct GFP-LC3
dots, an autophagy marker, appear in the cells treated with SK&F
96365 (Fig. 3A). When GFP-LC3 dots were counted in each cell (total
40–50 cells), the number of dots gradually increased in relation to
concentrations of SK&F 96365 (Fig. 3B). Western blot analysis
revealed that SK&F 96365 increases the level of LC3-II, a biomarker
of autophagy (Fig. 3C). In addition, time-lapse microscopic analysis
showed that an increase in GFP-LC3 dots appears after 2 h of
treatment with SK&F 96365 (Fig. 3D). These results demonstrate
that SK&F 96365 induces both apoptosis and autophagy.
To assess the speciﬁcity of SK&F 96365 action, we examined the
effects of other TRP channel blockers, which include LOE 908 [21], Pyr2,
Pyr3 [22,23], and 2APB [24], on apoptosis and autophagy. MTT assays
showed that the cytotoxic activities of TRP channel blockers aredifferentfrom each other (SFig. 3A–D). We then evaluated apoptosis in terms of
caspase activity using the blockers at the typically used concentrations
(10 μM LOE 908, 10 μM Pyr2, 10 μM Pyr3, and 100 μM 2APB). Among
these blockers, only 2APB was able to induce apoptosis (SFig. 3E).
However, GFP-LC3 puncta analysis showed that all four blockers do not
trigger autophagy (SFig. 3F). These results indicate that SK&F 96365
speciﬁcally induces both apoptosis and autophagy, probably via a TRP
channel-independent manner.
3.4. Suppression of apoptosis and autophagy promotes necrotic cell
death in A7r5 cells
Because several papers have reported that the combined suppres-
sion of apoptosis and autophagy enables necrosis [15,16], we
questioned the phenotypic consequence of concurrent suppression
of apoptosis and autophagy in the cells treated with SK&F 96365. We
ﬁrst ascertained that zVAD-fmk and/or 3-methyladenine (3-MA), a
type III PI3K inhibitor, does not affect cell viability (Fig. 4A). However,
SK&F 96365-induced cell death was not rescued by the combined
treatment of zVAD-fmk and 3-MA (Fig. 4B). We thus assessed necrotic
cell death using LDH release assays (Fig. 4C). SK&F 96365 caused
3-fold increase in LDH activity. Under these conditions, neither zVAD-
fmk nor 3-MA suppressed the elevated LDH activity. On the contrary,
co-treatment of zVAD-fmk and 3-MA resulted in 5.5-fold increase in
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apoptosis and autophagy provokes necrosis in the cells treated with
SK&F 96365.
To verify the functionality of zVAD-fmk and 3-MA, we ﬁrst
examined the cleavage of PARP, a caspase-3 substrate. SK&F 96365
produced a cleaved form of PARP, which is blocked by zVAD-fmk, butA
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calcium concentrations in A7r5 cells
To get a clue to the mechanisms of SK&F 96365-induced cell death,
we examined the effect of SK&F 96365 on cytoplasmic calcium
concentration ([Ca2+]cyt). As shown in Fig. 5A, SK&F 96365 did not
affect [Ca2+]cyt, whereas EGTA signiﬁcantly reduced [Ca2+]cyt. We
then measured the changes in cell viability depending on different
extracellular calcium concentrations ([Ca2+]ext). Lowering [Ca2+]ext
did not accelerate SK&F 96365-induced cell death (Fig. 5B). In
addition, elevated [Ca2+]ext failed to rescue the cell death (Fig. 5C).
These results indicate that SK&F 96365 induces cell death via the
mechanisms independent of intracellular or extracellular calcium
concentrations.
To evaluate the effect of SK&F 96365 on TRP channel activity,
particularly TRPM7 and TRPC5 in this study, we performed whole-cell
patch clamp analysis. SK&F 96365 at 6.25 μM (SFig. 5) or 12.5 μM
(data not shown) did not affect the currents of TRPM7 (SFig. 5A–C)
and TRPC5 (SFig. 5D–F). By contrast, SK&F 96365 at 100 μM inhibited
the currents of these TRP channels, suggesting that more than a dozen
concentrations of SK&F 96365 are effective in inhibiting TRP channel
activity. It is worthwhile to note that SK&F 96365 at 6.25 μM is able to
inﬂuence on the calcium mobilization pattern induced by AVP (SFig.
6A), whereas SK&F 96365 at 3.125 μM does not affect it (SFig. 6B).
Because 3.125 μM of SK&F 96365 is sufﬁcient to induce apoptosis and
autophagy (Figs. 1–3), our data suggest that the action of SK&F 96365
may be unrelated to calcium transport pathways.
3.6. SK&F 96365 inhibits Akt–mTOR signaling pathways in A7r5 cells
To understand themolecular actions of SK&F 96365, we performed
Western blot analysis with A7r5 cells. Because Akt–mTOR signaling
pathways antagonize both apoptosis and autophagy [12,14], we ﬁrst
assessed whether SK&F 96365 inhibits Akt–mTOR signaling. SK&F
96365 decreased the phosphorylation level of Akt at Ser-473, an
indicator of Akt activity, in a concentration-dependent manner
(Fig. 6A). These results were comparable with the phosphorylation
level of GSK-3β (an Akt substrate) and mTOR (an Akt effector). The
inhibition of Akt–mTOR signaling was observed following treatment
with SK&F 96365 for 30 min and sustained thereafter (Fig. 6B).
Moreover, the inhibitory action on Akt–mTOR signaling was speciﬁc
for SK&F 96365 and other TRP channel blockers did not inhibit Akt–
mTOR signaling (Fig. 6C).
To assess the usefulness of SK&F 96365 as a novel inhibitor of Akt–
mTOR signaling, we compared the cytotoxic efﬁcacy of SK&F 96365
with other known Akt inhibitors that have been developed as
anticancer agents. The IC50 values obtained from MTT assays were
approximately 3.18, 2.51, 5.04, and 2.7 μM for SK&F 96365, AKTi-1/2,
perifosine, and API-2, respectively (data not shown). At these
concentrations, all chemicals obviously inhibited Akt–mTOR signaling
(Fig. 6D).
4. Discussion
In this study, we demonstrate that SK&F 96365 induces apoptosis
and autophagy in A7r5 cells. Under the conditions, the concurrent
suppression of apoptosis and autophagy was found to causes necrotic
cell death. The cytotoxic activity of SK&F 96365 was unrelated to
calcium transport pathways. We also showed that SK&F 96365
inhibits Akt–mTOR signaling, which can underlie an important
mechanism of SK&F 96365-induced cell death.
The interaction between apoptosis and autophagy is exceptionally
complex and the underlying molecular mechanisms are poorly
understood [12]. Our data propose that SK&F 96365 is a useful chemical
probe to assess the crosstalk among cell death processes on the
molecular level. Thus, chemical biology with SK&F 96365 will assist indiscovering the molecular interactions governing relationship among
apoptosis, autophagy, and necrosis. In addition, we found that SK&F
96365 modulates Akt–mTOR signaling and Bcl-2 family expression,
which provides insight into the future research aimed to illuminate the
molecular mechanisms of SK&F 96365 actions.
Many Akt and mTOR inhibitors have been developed to treat
proliferation-related diseases, including restenosis and cancers [19].
Particularly, the loss-of-function mutations in PTEN leading to Akt–
mTOR activation are frequently observed in several types of cancers
[20]. We showed that the efﬁcacy of SK&F 96365 is comparable with
other Akt inhibitors, such as perifosine, Akti-1/2, and API-2. In our
preliminary study, we found that SK&F 96365 suppresses the cell
growth of PC-3 (IC50=3.28 μM) and LNCaP (IC50=1.52 μM), PTEN-
negative prostate cancer cell lines (data not shown). Therefore, these
data suggest that SK&F 96365 can be a promising anticancer agent
inhibiting Akt–mTOR signaling.
SK&F 96365 has been widely used to delineate the causal role of
TRP channels in the pathophysiological processes of cardiovascular or
nerve systems, typically in the range of 10–100 μM [6,7]. Of the TRP
channel blockers used, SK&F 96365 was found to have a potent
cytotoxic activity and inhibit Akt–mTOR signaling, suggesting that the
actions of SK&F 96365 are unrelated to TRP channel inhibition.
However, several questions still remain to be determined. Firstly, it is
needed to investigate whether SK&F 96365 at 6.25 μM can affect the
currents of other TRP channels rather than TRPM7 and TRPC5.
Secondly, most TRP channels are not exclusive to calcium and in fact
permeable to potassium, sodium, magnesium, and proton. In this
study, we did not address an issue concerning ion permeability or
selectivity. Thirdly, there is a possibility that TRP channels are
inhibited by SK&F 96365 via the Akt–mTOR signaling pathways.
Nonetheless, our results show that the treatment time and dosage of
SK&F 96365 should be carefully optimized to exclude its off-target
effects. In addition, our ﬁndings suggest that cautious interpretation is
required when SK&F 96365 is included in the assay systems.
In summary, our results demonstrated that SK&F 96365 induces
both apoptosis and autophagy in A7r5 cells. In addition, we showed
that SK&F 96365 is a novel inhibitor of Akt–mTOR signaling pathways.
Thus, our ﬁndings suggest that SK&F 96365 is a useful chemical probe
to assist in understanding cell death processes and their related
diseases.
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